Corporate presentation covering overview, history (since 1967), the 5 units, licensing & international sales (129 countries, 807 marketing authorizations), R&D, CMC & regulatory affairs, manufacturing (7,400 m² site, lyophilization 40M vials/yr, β-lactams 15M vials/yr, sterile liquids, oral dosage forms, serialization), logistics (3,500 m²), quality, and upcoming milestones.
English30 pages
brochure
ANFARM Product List Flyer
Two-page product-list flyer grouping the portfolio into dry powders / lyophilized, solutions for injection/infusion, non-sterile / oral dosage forms, and ongoing (ready-to-file) products with availability timelines.
English2 pages
catalog
ANFARM International Product List
International product list of ANFARM generic pharmaceuticals available for licensing and export.
English
Frequently asked questions
β-lactam antibiotics require containment segregation to prevent cross-contamination. Anfarm fills them in a dedicated Beta building with its own lines producing 15 million vials/year.
Approximately 15 million vials per year (~20 tons of API, average 1.3 g per vial) across an 880 m² dedicated area.
Pricing & samples
Anfarm Hellas S.A.
Source this product
Connect directly with Anfarm Hellas S.A. to request pricing, samples and lead times for β-Lactam Injectables: Cephalosporins & Carbapenems.
Overview
Sterile β-lactam antibiotics (cephalosporins and carbapenems) filled in a separate, dedicated Beta building to prevent cross-contamination. Fully upgraded and automated multi-filling-volume lines produce 15 million vials per year (≈20 tons of API, average 1.3 g per vial) across an 880 m² production area, under EU GMP.